Effective treatment of squamous cell carcinomas with ingenol mebutate gel in immunologically intact SKH1 mice

Ingenol mebutate has recently been approved by the Federal Drug Administration (USA) as a topical treatment for actinic keratoses. Herein, we describe the efficacy of ingenol mebutate for the topical treatment of squamous cell carcinoma (SCC) using a wild-type mouse model (SKH1) and the UV-induced m...

Descripción completa

Detalles Bibliográficos
Autores principales: Cozzi, Sarah-Jane, Le, Thuy T., Ogbourne, Steven M., James, Cini, Suhrbier, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2012
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3535356/
https://www.ncbi.nlm.nih.gov/pubmed/22871992
http://dx.doi.org/10.1007/s00403-012-1270-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3535356/
https://www.ncbi.nlm.nih.gov/pubmed/22871992
http://dx.doi.org/10.1007/s00403-012-1270-0

Ejemplares similares